From SINOTOP news center

Chinese Ministry of Agriculture recently released a list of pesticide product that plans to be granted registration, among which Bayer’s 94% fluoxastrobin technical will be granted temporary registration. This is the first time China registered fluoxastrobin product.

Fluoxastrobin was developed by Bayer in 1994 with its market focusing in the Europe and North America. In 2004, Bayer mixed fluoxastrobin with prothioconazole and launched it with brand name Fandango. Arysta obtained distribution right of fluoxastrobin in 2005 and was responsible for the market development in US, Canada and Japan, along for the global marketing for non-crop.

Arysta singed another agreement with Bayer in 2012, acquiring exclusive distribution right of fluoxastrobin both in crop and non-crop, while Bayer held the right to develop and market its use in seed treatment and some specific formulated product.

Through a series licensing and cooperation, Arysta has successfully launched two product lines Evito and Disarm for F&V and turf respectively. The company has started to collaborate with others including Isagro, chemtura and FMC to jointly develop the fluoxastrobin in global market.

Just in last week, Arysta has published the new fungicide product of Evito in China. Evito will be launched later this year and another product with a different concentration will be launched in 2017. The fluoxastrobin series will inject some new energy into China’s fungicide market.

The global sales of fluoxastrobin in 2014 has reached $ 220 million.